The purpose of this study is to evaluate the safety and tolerability of multiple doses of MAR001in adult volunteers with metabolic dysfunction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
55
Brisbane Site
Brisbane, Australia
Melbourne Site
Melbourne, Australia
Safety and tolerability of MAR001
Incidence and frequency of treatment-emergent adverse events
Time frame: 12 weeks
Effect of MAR001 on triglyceride metabolism
Change from baseline in triglyceride levels
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.